Biogen Idec Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT and Financial Report

Publication date: November 2012
Report size: 31 pages

Keywords : rheumatoid arthritis, Crohn's disease, Psoriasis, lymphoma

Synopsis ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history. Summary This report is a crucial resource for industry executives and anyone looking to access key ...

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Synopsis
ICD Research's "Biogen Idec Inc.: Pharmaceuticals and Healthcare - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, and company history.

Summary
This report is a crucial resource for industry executives and anyone looking to access key information about "Biogen Idec Inc."

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
- Examines and identifies key information and issues about "Biogen Idec Inc." for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- Provides data on company financial performance.
- The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.

Reasons To Buy
- Quickly enhance your understanding of "Biogen Idec Inc."
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors' businesses better.
- Recognize potential partnerships and suppliers.

Key Highlights
Biogen Idec Inc. (Biogen) is a leading biotechnology company focusing on the development, manufacturing and commercialization of therapies used in the areas of oncology, neurology, immunology and cardiology. It offers products to address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, chronic lymphocytic leukemia and psoriasis. It has a broad pipeline of products in clinical trials. The company primarily markets four products, AVONEX, RITUXAN, TYSABRI and FUMADERM worldwide, principally in Canada, Australia, Japan and Europe. Biogen is headquartered in Cambridge, Massachusetts, the US.

Global Pathology Industry

Musculoskeletal Disorder in World